BlackRock
CADL icon

BlackRock’s Candel Therapeutics CADL Stock Holding History

BlackRock’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.2M Buy
3,109,042
+247,353
+9% +$1.35M ﹤0.01% 3239
2025
Q4 		$16.2M Buy
2,861,689
+482,359
+20% +$2.59M ﹤0.01% 3202
2025
Q3 		$12.1M Buy
2,379,330
+77,485
+3% +$448K ﹤0.01% 3351
2025
Q2 		$11.6M Buy
2,301,845
+538,075
+31% +$2.77M ﹤0.01% 3336
2025
Q1 		$9.97M Buy
1,763,770
+579,823
+49% +$4.74M ﹤0.01% 3327
2024
Q4 		$10.3M Buy
1,183,947
+58,268
+5% +$344K ﹤0.01% 3416
2024
Q3 		$7.8M Buy
1,125,679
+302,608
+37% +$1.88M ﹤0.01% 3532
2024
Q2 		$5.1M Buy
823,071
+775,491
+1,630% +$5.82M ﹤0.01% 3675
2024
Q1 		$75.2K Sell
47,580
-1,705
-3% -$2.53K ﹤0.01% 4796
2023
Q4 		$72.5K Sell
49,285
-564
-1% -$548 ﹤0.01% 4891
2023
Q3 		$45.9K Sell
49,849
-1,974
-4% -$2.28K ﹤0.01% 5021
2023
Q2 		$65.3K Buy
51,823
+5,279
+11% +$7.8K ﹤0.01% 5020
2023
Q1 		$62.8K Buy
46,544
+7,497
+19% +$14.6K ﹤0.01% 5073
2022
Q4 		$69.9K Sell
39,047
-85,923
-69% -$170K ﹤0.01% 5144
2022
Q3 		$393K Sell
124,970
-4,407
-3% -$14.9K ﹤0.01% 4795
2022
Q2 		$420K Sell
129,377
-2,945
-2% -$11.8K ﹤0.01% 4829
2022
Q1 		$674K Buy
132,322
+17,708
+15% +$87.9K ﹤0.01% 4791
2021
Q4 		$896K Buy
114,614
+92,288
+413% +$896K ﹤0.01% 4699
2021
Q3 		$242K Buy
+22,326
New +$185K ﹤0.01% 4940

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HFF
Halter Ferguson Financial Carmel, Indiana $456M AUM 49.85% 1-Year Est. Return

BlackRock's CADL Position: Q1 2026 in Review

BlackRock increased its Candel Therapeutics (CADL) stake by 8.6% in Q1 2026, buying an estimated $1.35M and bringing the position to 3,109,042 shares worth $15.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3239.

BlackRock first reported a position in CADL in Q3 2021 and has held it in 19 quarters since. The position peaked at $16.2M in Q4 2025. 114 funds tracked by Wall St. Rank hold CADL as of Q1 2026.

  • BlackRock held 3,109,042 shares of Candel Therapeutics worth $15.2M as of Q1 2026.
  • BlackRock bought 247,353 Candel Therapeutics shares in Q1 2026, an estimated $1.35M.
  • Candel Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #3239 holding.
  • BlackRock first reported a position in Candel Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • BlackRock's Candel Therapeutics position peaked at $16.2M in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Candel Therapeutics as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.